Non-Current Assets

Intangible assets — net

Moderna Intangible assets — net increased by 157.8% to $116.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 136.7%, from $49.00M to $116.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ4 2022
Last reportedQ1 2026May 1, 2026

How to read this metric

Higher values indicate significant investment in proprietary technology or market access, though they require monitoring for potential impairment.

Detailed definition

This represents the net value of identifiable intangible assets with a limited useful life, such as patents, licenses, o...

Peer comparison

Common in technology, pharmaceutical, and defense firms that acquire or develop proprietary intellectual property.

Metric ID: non_current_assets_finite_lived_intangible_assets_net

Historical Data

14 periods
 Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$48.00M$46.00M$45.00M$44.00M$43.00M$42.00M$41.00M$40.00M$49.00M$48.00M$47.00M$45.00M$116.00M
QoQ Change-4.2%-2.2%-2.2%-2.3%-2.3%-2.4%-2.4%+22.5%-2.0%-2.1%-4.3%+157.8%
YoY Change-10.4%-8.7%-8.9%-9.1%+14.0%+14.3%+14.6%+12.5%+136.7%
Range$0.00$116.00M
Avg YoY Growth+17.2%
Median YoY Growth+12.5%

Frequently Asked Questions

What is Moderna's intangible assets — net?
Moderna (MRNA) reported intangible assets — net of $116.00M in Q1 2026.
How has Moderna's intangible assets — net changed year-over-year?
Moderna's intangible assets — net increased by 136.7% year-over-year, from $49.00M to $116.00M.
What does intangible assets — net mean?
The value of non-physical assets with a limited lifespan, like patents or licenses.